• Chines33
    Pharma still consolidating as well but favorites names should be bough on weakness $PFE $MRK $BMY if you are a long term investor.
    Reply (2)
    • Chines33: I also like $GSK(new approvals down the line in pipe with nice Div) and $HCA in that mix.
    • mitrado: What weakness? They are all way above my target prices. I've bough $MRK at $30 but I've sold it a long time ago.